lamictal
Generic: lamotrigine
Labeler: glaxosmithkline llcDrug Facts
Product Profile
Brand Name
lamictal
Generic Name
lamotrigine
Labeler
glaxosmithkline llc
Dosage Form
TABLET, FOR SUSPENSION
Routes
Active Ingredients
lamotrigine 25 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0173-0527
Product ID
0173-0527_4492fd3c-e068-4599-8a10-0b26ea2a4f91
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA020764
Listing Expiration
2026-12-31
Marketing Start
1998-09-03
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
01730527
Hyphenated Format
0173-0527
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lamictal (source: ndc)
Generic Name
lamotrigine (source: ndc)
Application Number
NDA020764 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 25 mg/1
Packaging
- 100 TABLET, FOR SUSPENSION in 1 BOTTLE (0173-0527-00)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4492fd3c-e068-4599-8a10-0b26ea2a4f91", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "upc": ["0301730526007", "0301730644602", "0301730699008", "0301730642554", "0301730643605", "0301730527004"], "unii": ["U3H27498KS"], "rxcui": ["103968", "105018", "105019", "108782", "198427", "198428", "198429", "198430", "201239", "201240", "206201", "252478", "252479", "282401", "311264", "311265", "349010", "542426", "751139", "751563", "753451", "795772", "795774", "795778", "849049", "849050", "849051", "849052", "851748", "851749", "851750", "851751", "851752", "851753"], "spl_set_id": ["d7e3572d-56fe-4727-2bb4-013ccca22678"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["GlaxoSmithKline LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FOR SUSPENSION in 1 BOTTLE (0173-0527-00)", "package_ndc": "0173-0527-00", "marketing_start_date": "19980903"}], "brand_name": "LAMICTAL", "product_id": "0173-0527_4492fd3c-e068-4599-8a10-0b26ea2a4f91", "dosage_form": "TABLET, FOR SUSPENSION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "0173-0527", "generic_name": "lamotrigine", "labeler_name": "GlaxoSmithKline LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LAMICTAL", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "25 mg/1"}], "application_number": "NDA020764", "marketing_category": "NDA", "marketing_start_date": "19980903", "listing_expiration_date": "20261231"}